---
id: pleural-effusion-emergency
condition: Pleural Effusion — Emergency Presentations
aliases: [massive pleural effusion, tension hydrothorax, parapneumonic effusion, hemothorax, malignant effusion acute]
icd10: [J91.0, J91.8, J90]
esi: 2
time_to_harm: "< 4 hours (massive effusion with respiratory compromise)"
category: respiratory
track: tier1
sources:
  - type: guideline
    ref: "2010 BTS Guideline for Investigation of a Unilateral Pleural Effusion in Adults. Thorax. 2010;65(Suppl 2):ii4-ii17."
  - type: guideline
    ref: "2018 BTS Guideline for Pleural Disease. Thorax. 2023."
  - type: review
    ref: "Feller-Kopman D, Light R. Pleural Disease. N Engl J Med. 2018;378(8):740-751."
last_updated: "2026-03-01"
compiled_by: agent
risk_tier: B
validation:
  automated_consistency_check: null
  dose_range_validator: null
  unit_normalization_check: null
  cross_file_consistency_check: null
  citation_presence_check: null
  duplicate_content_check: null
  outlier_detection_flag: clear
  schema_version: "2.0"
  provenance_links: []
---
# Pleural Effusion — Emergency Presentations

## Recognition

**Presentation:**
- Dyspnea (most common), progressive and positional (worse lying flat)
- Pleuritic chest pain (inflammatory/infectious causes)
- Decreased breath sounds on affected side
- Dullness to percussion
- Decreased tactile fremitus
- Tracheal deviation AWAY from effusion (massive effusion/tension hydrothorax)
- Hypoxia, tachypnea

**Tension hydrothorax (emergency):**
- Massive effusion with mediastinal shift
- Hemodynamic compromise: hypotension, tachycardia
- Contralateral tracheal deviation
- Requires emergent drainage — can be rapidly fatal

**Light's criteria (transudative vs exudative):**
- Exudate if ANY one criterion met:
  - Pleural protein/serum protein > 0.5
  - Pleural LDH/serum LDH > 0.6
  - Pleural LDH > 2/3 upper limit of normal serum LDH

**Common etiologies:**
- **Transudative:** CHF (most common overall), cirrhosis, nephrotic syndrome, PE
- **Exudative:** Pneumonia/parapneumonic (most common exudate), malignancy, TB, PE, autoimmune, pancreatitis

## Critical Actions

| Action | Target |
|---|---|
| CXR or bedside US | < 15 minutes |
| Emergent thoracentesis (if tension) | < 30 minutes |
| Supplemental O2 | Immediate |

1. **Supplemental oxygen** — titrate to SpO2 > 92%
2. **Chest X-ray** (upright PA/lateral) — blunting of costophrenic angle (> 200 mL); complete opacification = massive effusion. Lateral decubitus film shows layering.
3. **Bedside ultrasound** — superior sensitivity to CXR; identifies effusion, estimates volume, guides drainage, detects septations
4. **Emergent therapeutic thoracentesis** for tension hydrothorax or severe respiratory compromise
5. **Tube thoracostomy** for hemothorax or empyema
6. **Diagnostic thoracentesis** for new effusion of unclear etiology — send fluid for: cell count/differential, protein, LDH, glucose, pH, gram stain, culture, cytology

## Differential Diagnosis

- **Pneumonia with parapneumonic effusion** — fever, productive cough, consolidation on imaging
- **Hemothorax** — trauma, anticoagulation, malignancy; pleural hematocrit > 50% of blood hematocrit
- **Empyema** — purulent fluid, pH < 7.2, glucose < 40, positive cultures/gram stain
- **Malignant effusion** — recurrent, unilateral, lymphocyte-predominant, positive cytology (sensitivity ~60%)
- **CHF** — bilateral, transudative, response to diuresis
- **Chylothorax** — milky fluid, elevated triglycerides > 110 mg/dL, lymphocyte predominant
- **Pulmonary embolism** — can cause either transudative or exudative effusion

## Workup

- **Chest X-ray:** Upright PA/lateral — blunting at 200 mL, meniscus sign, complete opacification
- **Bedside ultrasound:** Free-flowing vs loculated; anechoic (transudate) vs complex/septated (exudate/empyema)
- **CT chest with contrast:** If underlying cause unclear, loculated effusion, or malignancy suspected
- **Thoracentesis fluid analysis:**
  - Cell count + differential (neutrophil-predominant = acute inflammation; lymphocyte-predominant = malignancy, TB)
  - Protein, LDH (Light's criteria)
  - Glucose (< 40 = empyema, rheumatoid, malignancy)
  - pH (< 7.2 = complicated parapneumonic/empyema → tube thoracostomy)
  - Gram stain, bacterial culture, AFB
  - Cytology (malignancy)
  - Triglycerides (chylothorax if > 110)
  - Amylase (pancreatitis, esophageal rupture)
  - Hematocrit (hemothorax if > 50% of blood Hct)
- **Labs:** CBC, BMP, LDH, total protein, albumin, BNP (if CHF suspected)

## Treatment

### Emergent Drainage
- **Tension hydrothorax:** Needle decompression (14-16G angiocath, 2nd ICS midclavicular or 5th ICS midaxillary) → followed by tube thoracostomy
- **Hemothorax:** Tube thoracostomy (28-32 Fr) — surgical consultation if > 1500 mL initial drainage or > 200 mL/hr ongoing
- **Empyema:** Tube thoracostomy + intrapleural fibrinolytics (tPA 10 mg + DNase 5 mg q12h x 3 days per MIST2 protocol) if loculated

### Therapeutic Thoracentesis
- Ultrasound-guided (reduces pneumothorax to ~3%)
- Remove up to 1000-1500 mL per session (slow drainage)
- Stop if patient develops cough, chest tightness, or pleuritic pain (re-expansion pulmonary edema risk)
- Post-procedure CXR recommended (or lung US to assess)

### Transudative Effusion
- Treat underlying cause: diuresis for CHF (furosemide 40-80 mg IV), albumin for cirrhosis/nephrotic
- Thoracentesis for symptomatic relief; drainage alone is temporizing

### Parapneumonic Effusion (Uncomplicated)
- Antibiotics per pneumonia guidelines — effusion often resolves with treatment
- If pH >= 7.2, glucose >= 40, gram stain/culture negative: antibiotics alone sufficient
- If pH < 7.2, glucose < 40, purulent, or positive culture: tube thoracostomy required (complicated effusion/empyema)

### Malignant Effusion
- Therapeutic thoracentesis for symptom relief
- Indwelling pleural catheter (PleurX) for recurrent symptomatic effusion
- Talc pleurodesis (50% dextrose + talc slurry via chest tube) for patients with expected survival > 1 month and expandable lung

## Disposition

- **ICU admission:** Tension hydrothorax, massive hemothorax, respiratory failure requiring intubation
- **Inpatient admission:** Empyema, complicated parapneumonic effusion, new large effusion requiring workup, hemothorax
- **Observation/short stay:** Therapeutic thoracentesis with symptomatic improvement, known recurrent effusion
- **Discharge:** Small stable effusion in known CHF patient after diuresis, follow-up imaging arranged
- **Surgical consultation:** Hemothorax > 1500 mL or > 200 mL/hr, retained hemothorax, loculated empyema failing fibrinolytics

## Pitfalls

1. **Not recognizing tension hydrothorax as a medical emergency.** Massive pleural effusion with mediastinal shift can cause cardiac compression and obstructive shock mimicking tension pneumothorax. Emergent drainage is life-saving.

2. **Draining too rapidly or too much fluid.** Removing > 1500 mL at once risks re-expansion pulmonary edema (RPE) — flash pulmonary edema in the ipsilateral lung after rapid drainage. Drain slowly and stop if the patient develops cough, chest tightness, or pain.

3. **Performing thoracentesis without ultrasound guidance.** Landmark-based thoracentesis has a pneumothorax rate of ~10-20%. US-guided thoracentesis reduces this to ~3%. Ultrasound should be used for all thoracenteses.

4. **Missing empyema by not sending pH and glucose on pleural fluid.** pH < 7.2 and glucose < 40 identify complicated parapneumonic effusions that require tube thoracostomy — antibiotics alone will fail. Always send these studies on exudative effusions.

5. **Attributing a large unilateral effusion to CHF without further workup.** CHF typically causes bilateral effusions (right > left). A unilateral effusion, especially on the left, warrants diagnostic thoracentesis to exclude malignancy, PE, or infection.
